Related Experiment Video
Updated: Feb 4, 2026

Engineered Vascularized Muscle Flap
Published on: January 11, 2016
Vascular Intervention: From Angioplasty to Bioresorbable Vascular Scaffold
1Departments of Neurosurgery and of Biomedical Engineering, Yale University, New Haven, CT, USA.
Insights
Bioresorbable vascular scaffolds (BVSs) offer a promising alternative to metallic stents for coronary artery disease, potentially avoiding long-term complications. Further research is needed to fully demonstrate their clinical advantages.
Area of Science:
- Cardiovascular research
- Biomaterials science
- Medical device engineering
Background:
- Coronary artery disease (CAD) is a major global health concern.
- Metallic stents, while effective, cause long-term arterial issues like inflammation and restenosis.
- Bioresorbable vascular scaffolds (BVSs) are being developed to overcome these limitations.
Purpose of the Study:
- To review the historical development of nonsurgical vascular interventions.
- To discuss the current state of bioresorbable vascular scaffold technology.
- To identify and propose solutions for existing BVS limitations.
Main Methods:
- Literature review of nonsurgical vascular intervention evolution.
- Analysis of current bioresorbable vascular scaffold development.
- Exploration of potential strategies to address BVS challenges.
Main Results:
- Metallic stents have limitations including impaired arterial physiology and adverse effects.
- Bioresorbable vascular scaffolds (BVSs) offer temporary support and are resorbed, potentially improving arterial remodeling.
- The theoretical benefits of BVSs require further clinical validation.
Conclusions:
- BVSs represent a promising advancement over metallic stents for CAD treatment.
- Addressing current BVS limitations is crucial for realizing their full clinical potential.
- Continued research and development are essential for the successful implementation of BVSs.
Abstract:
Coronary artery disease (CAD) is the leading cause of mortality and morbidity worldwide. Clinically, CAD can be potentially managed through surgical artery bypass. However, due to the highly invasive nature, surgical intervention has been gradually replaced by percutaneous transluminal coronary angioplasty and recently by percutaneous coronary revascularization using metallic stents. However, the permanent presence of metallic scaffolds inevitably impairs arterial physiology and may induce a variety of adverse effects, such as inflammation, restenosis, thrombosis, and neoatherosclerosis. To address these limitations, revascularization using bioresorbable vascular scaffolds (BVSs) has emerged as the most promising approach. After angioplasty, BVSs provide temporarily mechanical support and are completely resorbed over defined time. This transient nature allows favorable arterial remodeling and avoids thrombosis and in-stent restenosis. However, the theoretical advantages of BVSs have yet to be demonstrated. In this chapter, we first review the evolution of nonsurgical vascular intervention approaches over the past few decades. Next, we discuss the current status of BVS development and propose potential approaches to addressing the limitations associated with the current BVSs.
Related Concept Videos
Seedless Vascular Plants
Vascular Spasm
Overview of the Vascular System
Vascular Resistance
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
Non-vascular Seedless Plants
Inflammatory Response I: Vascular and Cellular

